Alendronate sodium
Alendronate Sodium
Alendronate Sodium (pronunciation: a-LEN-droe-nate SOE-dee-um) is a bisphosphonate medication primarily used to treat and prevent osteoporosis in postmenopausal women. It is also used to treat Paget's disease of bone.
Etymology
The term "Alendronate" is derived from the chemical name of the drug, which is 4-amino-1-hydroxybutylidene bisphosphonic acid monosodium salt. The "sodium" in "Alendronate Sodium" refers to the sodium salt form of the drug.
Usage
Alendronate Sodium works by slowing bone loss, helping to maintain bone mass and reduce the chance of fractures. It belongs to a class of drugs known as bisphosphonates.
Related Terms
- Bisphosphonates: A class of drugs that prevent the loss of bone density.
- Osteoporosis: A condition characterized by weak and brittle bones.
- Paget's disease: A condition that interferes with the body's normal bone recycling process.
Side Effects
Common side effects of Alendronate Sodium include abdominal pain, nausea, and heartburn. More serious side effects can include jawbone problems and unusual fractures of the thigh bone.
Precautions
Before taking Alendronate Sodium, patients should inform their healthcare provider if they have any conditions such as esophagus problems, difficulty swallowing, low blood calcium levels, kidney disease, or cannot sit or stand for at least 30 minutes.
Interactions
Alendronate Sodium may interact with other medications, including calcium supplements, antacids, and other oral medications.
External links
- Medical encyclopedia article on Alendronate sodium
- Wikipedia's article - Alendronate sodium
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski